The recent analysis published by Nature on January 21, 2026, titled "How one year of the Trump administration has impacted US science," has sparked widespread discussion among researchers, policymakers, and academic leaders. This in-depth report, building on earlier immersive graphics from January 20, synthesizes data, interviews, and visualizations to quantify the disruptions while highlighting resilience in the US scientific enterprise. Drawing from crowdsourced databases and federal records, it reveals a tumultuous first year marked by proposed budget slashes, grant terminations, and workforce reductions, yet tempered by congressional interventions and enduring institutional strengths.
At its core, the report underscores how executive actions have reshaped federal funding for science, particularly affecting agencies like the National Institutes of Health (NIH), National Science Foundation (NSF), and Environmental Protection Agency (EPA). These changes ripple through universities and research labs nationwide, influencing everything from basic research grants to applied innovation projects. As the US navigates this landscape, understanding these shifts is crucial for scientists planning their next steps, from grant applications to career pivots.
Nature's Data-Driven Breakdown of the First Year
The Nature analysis compiles staggering figures: nearly $1.4 billion in NIH and NSF grants discontinued, alongside over $28 billion in EPA grants terminated, according to a crowdsourced database referenced in the report. These aren't abstract numbers; they represent halted projects on cancer research, climate modeling, and AI advancements. The publication uses interactive graphics to illustrate trends, showing a sharp decline in federal research obligations since January 2025.
Step-by-step, the disruptions unfolded: In the first 30 days, executive orders targeted "wasteful" programs, leading to immediate grant reviews. By mid-year, mass layoffs hit agencies, with political appointees prioritizing certain fields like defense-related tech over environmental or public health studies. Nature's timeline maps this progression, noting peaks in terminations around budget proposal releases in spring 2025.
- January 2025: Initial freeze on new grants.
- March 2025: White House proposes 20-30% cuts to non-defense R&D.
- September 2025: Congress debates, partially restoring funds.
- December 2025: Year-end layoffs affect 10-15% of federal science staff.
Budget Battles: Proposed Cuts vs. Congressional Reality
The Trump administration's fiscal blueprint called for billions in reductions, but Congress pushed back decisively. A New York Times report from January 10, 2026, details how senators and representatives safeguarded basic research, boosting funds for NSF and NIH beyond pre-2025 levels in some areas. This bipartisan effort—driven by concerns over US competitiveness against China—mitigated the worst proposals.
| Agency | Proposed Cut (2026 Budget) | Congressional Outcome |
|---|---|---|
| NIH | $5B reduction | Minimal cut, +2% increase |
| NSF | $2B slash | Restored to flat funding |
| EPA Science | 50% cut | 25% reduction after negotiations |
Experts attribute this to lobbying from university consortia and industry groups, emphasizing science's role in economic growth. For context, federal R&D funding constitutes about 40% of US academic research budgets, making these battles pivotal for institutions like MIT and UC Berkeley.
The Human Cost: Researchers' Stories of Disruption
Nature's companion piece, "‘Shattered’: US scientists speak out," profiles individuals whose careers were upended. Dr. Maria Gonzalez, a climate researcher at a Midwest university, saw her $2 million EPA grant axed, forcing her lab to downsize from 12 to 3 members. "It felt like the ground vanished," she told Nature. Similar tales emerge from biomedical fields, where postdocs scramble for extensions amid NIH uncertainties.
Quantitative impact: Earth science publications by US authors hit a 20-year low, per analyses cited in social media discussions around the report. This brain drain risks long-term innovation gaps, as early-career scientists pivot to private sector roles or emigrate.
Agency-Specific Impacts: NIH, NSF, and Beyond
The NIH, funding 80% of US biomedical research, faced grant halts totaling hundreds of millions, delaying clinical trials for diseases like Alzheimer's. NSF, steward of basic science, saw physics and engineering proposals deprioritized. EPA cuts hit environmental monitoring hardest, with programs tracking air quality and biodiversity terminated.
In higher education, this translates to lab closures at state universities. For instance, a case study from the University of Colorado highlights 40% funding loss for atmospheric research, prompting faculty buyouts. Yet, some fields like quantum computing gained via defense reallocations.
Photo by Aaron Burden on Unsplash
Resilience and What Endures in US Science
Not all is bleak. Nature's report, "US science after a year of Trump: what has been lost and what remains," spotlights strengths: Private philanthropy surged 15%, with foundations like Gates and Wellcome filling gaps. Universities adapted via endowments, and industry partnerships boomed in biotech.
Political appointees notwithstanding, core infrastructure—national labs, supercomputing centers—persists. A January 14 Nature outlook predicts brighter budgets for 2026, with science agencies regaining autonomy.
Broader Ramifications for Innovation and Economy
US science drives 55% of global citations and fuels GDP growth via patents. Disruptions risk ceding ground to rivals; China's R&D spend overtook the US in 2025. Stakeholders from academia warn of slowed drug discoveries and clean energy transitions.
- Innovation lag: 20% drop in federally funded startups.
- Economic hit: $10B+ in lost research output.
- Equity issues: Minority-serving institutions hardest hit.
For higher ed, this means tighter belts but opportunities in research positions emphasizing private funding.
Expert Voices: Multi-Perspective Analysis
Experts diverge: Union of Concerned Scientists decries a "war on science," while Heritage Foundation allies praise efficiency. The Atlantic (Dec 31, 2025) laments paralyzed ambition, but optimists like NSF Director nominees foresee streamlined priorities.
University presidents, in Nature interviews, urge diversified funding: "Federal cuts force us to innovate partnerships," says Stanford's provost.
Read scientists' personal accountsFuture Trajectories: 2026 and Beyond
Looking ahead, Nature's January 14 piece outlines five themes: stabilized budgets, appointee influences, AI/biotech booms, climate research squeezes, and international collaborations. Midterm elections could amplify pushback.
Projections: R&D funding to rise 5% if Congress prevails, per CBO estimates. Researchers should monitor OSTP guidelines for grant realignments.
Practical Strategies for Researchers and Academics
To thrive amid uncertainty:
- Diversify funding: Target NSF's untouched programs or private grants.
- Build networks: Join consortia like AAAS for advocacy.
- Upskill: Focus on high-priority areas like quantum or defense tech.
- Explore opportunities: Platforms like AcademicJobs.com higher ed jobs list resilient positions.
Career advice abounds in resources like how to craft a winning academic CV, essential for navigating transitions.
Photo by Bernd 📷 Dittrich on Unsplash
Navigating the New Normal in US Science
One year in, the Trump administration's imprint on US science is profound yet not fatal. Nature's analysis serves as a wake-up call and roadmap, blending alarm with agency. For academics eyeing stability, consider professor jobs, postdoc openings, or faculty roles buffered by endowments. Explore Rate My Professor for institution insights, and arm yourself with higher ed career advice. As science adapts, opportunities emerge for the prepared.